Private corrections company GEO Group (NYSE: GEO) reported revenue ahead of Wall Street’s expectations in Q2 CY2026, with sales up 15.1% year on year to $732.1 million. Guidance for next quarter’s revenue was better than expected at $780 million at the midpoint, 1.9% above analysts’ estimates. Its GAAP profit of $0.36 per share was 26.2% above analysts’ consensus estimates.

Is now the time to buy GEO? Find out in our full research report (it’s free for active Edge members).

StockStory’s Take

GEO Group’s second quarter was marked by contract-driven growth and a significant expansion in federal partnerships, but the market responded negatively despite results that exceeded Wall Street’s expectations. Management attributed the strong revenue and profit gains to new and expanded contracts with agencies like ICE and the US Marshals Service, particularly noting increased facility activations and a shift toward more intensive monitoring in its ISAP program. CEO George Zoley emphasized that “our better than expected performance reflects significant revenue growth from the contracts that we entered into throughout 2025,” highlighting the impact of last year’s record new business wins and recent policy changes affecting facility utilization.

Looking ahead, GEO Group’s updated outlook is influenced by continued ICE funding and the ramp-up of new facility activations, though some delays and policy uncertainties persist. Management cited expectations of normalized operations at newly reactivated sites in early 2027 and sees additional upside potential from possible further contract awards, shifts in technology usage within its monitoring programs, and the prospect of asset sales to ICE. CFO Shayn March noted, “our updated guidance does not include any earnings contribution from our new Bighorn and Rivers contracts since we expect the activation period for these facilities to be completed by the end of 2026,” while also acknowledging potential future growth if more idle facilities are reactivated or if policy shifts increase overall population counts.

Key Insights from Management’s Remarks

Management pointed to new contract wins, ICE policy changes, and technology adoption as major drivers of performance and near-term strategy.

• ICE contract expansion: The company secured new and expanded contracts with ICE, activating more than 6,000 detention beds across four facilities. This brought GEO’s total active ICE beds to about 27,000, representing over a third of the national ICE population, and positioned the company to benefit from federal efforts to consolidate and expand immigration detention capacity.

• Facility reactivations: GEO entered into five-year contracts to reactivate two previously idle facilities—Bighorn in Colorado and Rivers in North Carolina—expected to add $165 million in annual revenue once fully operational. ICE will reimburse GEO for related capital expenditures, reducing upfront costs and enabling rapid deployment.

• Shift in monitoring technology: The ISAP-V program, which provides electronic monitoring for non-detained immigrants, continued to shift toward higher-priced ankle monitors and more intensive case management services. The number of participants on GPS ankle monitors rose from 17,000 to 54,000 over the past year, supporting revenue even as overall participation remained stable.

• Secure transportation services growth: GEO expanded its secure transportation services for both ICE and the US Marshals Service, signing new contracts and increasing the scope of existing agreements. This includes significant additions to ground and air transport, which are expected to contribute approximately $20 million in annual revenue once new facilities are fully ramped.

• Potential asset sales to ICE: Management discussed ongoing negotiations with ICE regarding the potential sale of company-owned turnkey processing centers, with a focus on retaining long-term support services contracts post-sale. Recent similar transactions by competitors suggest valuations above $300,000 per bed, which could provide GEO with significant liquidity for debt repayment and share buybacks if consummated.

Drivers of Future Performance

GEO’s outlook is shaped by government policy on detention capacity, facility activations, and evolving technology use in monitoring programs.

• ICE detention policy and funding: Management expects ICE’s ongoing push to expand detention capacity to 100,000 beds and consolidate operations into larger facilities to drive future contract opportunities. The Secure America Act’s multi-year funding, along with additional appropriations, is likely to support GEO’s growth in both new facility activations and reactivation of idle assets.

• Technology mix and monitoring services: The continued shift in the ISAP-V program from app-based monitoring to more intensive and higher-priced ankle monitoring and case management is expected to support revenue growth, even if overall participant numbers remain flat. Management highlighted the potential for further upside if ICE policy shifts increase the number of monitored individuals or specific populations, such as Haitian immigrants, are prioritized for monitoring.

• Asset sales and capital allocation: The potential sale of several facilities to ICE could provide GEO with substantial liquidity. Management intends to prioritize debt reduction and shareholder returns, but timing is uncertain due to the government procurement process. Restrictions in current debt agreements may influence how proceeds are allocated, but new asset sales could materially impact the company’s balance sheet and capital strategy.

Catalysts in Upcoming Quarters

Looking ahead, the StockStory team will be watching (1) the pace and completion of new facility activations and further contract wins with ICE, (2) progress on potential asset sales to ICE and any resulting changes to capital allocation, and (3) the impact of technology mix shifts in the ISAP-V program on revenue and margins. Outcomes related to policy changes or budgetary developments could also influence the company’s performance.

GEO Group currently trades at $30.49, down from $31.46 just before the earnings. Is the company at an inflection point that warrants a buy or sell? See for yourself in our full research report (it’s free).

Stocks That Trumped Tariffs

WHILE YOU’RE HERE: Top 9 Market-Beating Stocks. The best stocks don’t just beat the market once. They do it again. And again. Robust revenue growth, rising free cash flow, returns on capital that leave their competition in the dust. The market has already rewarded these businesses.

But our AI platform says the party isn’t over. Find out which 9 stocks made the cut this week — FREE. Get Our Top 9 Market-Beating Stocks for Free HERE.

Stocks that have made our list include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+271% between June 2020 and June 2025). Find your next big winner with StockStory today.